Cerebrospinal fluid neurogranin in Alzheimer’s disease studies: are immunoassay results interchangeable?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry and laboratory medicine 2022-01, Vol.60 (1), p.13-17
Hauptverfasser:	Aveneau, Clément, Hourregue, Claire, Cognat, Emmanuel, Dumurgier, Julien, Vanderstichele, Hugo, Vanmechelen, Eugeen, Zetterberg, Henrik, Hugon, Jacques, Blennow, Kaj, Paquet, Claire, Bouaziz-Amar, Elodie
Format:	Artikel
Sprache:	eng
Schlagworte:	Agreements Alzheimer Disease - cerebrospinal fluid Alzheimer Disease - diagnosis Alzheimer's disease Amyloid beta-Peptides - cerebrospinal fluid Bias biomarker Biomarkers Biomarkers - cerebrospinal fluid Calibration Cerebrospinal fluid Clinical medicine Cognitive Dysfunction - cerebrospinal fluid Dementia Humans Immunoassay Letter to the Editor Monoclonal antibodies Neurodegenerative diseases Neurogranin Neurogranin - cerebrospinal fluid Patients Proteins Regression analysis tau Proteins - cerebrospinal fluid Variance analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!